Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Katherine Frasca

Concepts (72)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sexual and Gender Minorities
3
2022
215
1.490
Why?
HIV Infections
8
2022
2837
1.390
Why?
Anti-HIV Agents
6
2022
778
1.260
Why?
Pre-Exposure Prophylaxis
3
2022
213
0.860
Why?
Coinfection
2
2014
137
0.810
Why?
Community Health Services
2
2014
227
0.790
Why?
Tuberculosis
2
2014
279
0.710
Why?
AIDS Serodiagnosis
1
2018
24
0.590
Why?
Dried Blood Spot Testing
1
2019
104
0.580
Why?
Emtricitabine
1
2019
175
0.560
Why?
Viral Load
1
2019
469
0.530
Why?
Sexual Behavior
1
2019
485
0.450
Why?
Program Evaluation
1
2019
901
0.450
Why?
Vancomycin Resistance
1
2012
16
0.400
Why?
Oxazolidinones
1
2012
15
0.400
Why?
Enterococcus
1
2012
23
0.390
Why?
Acetamides
1
2012
36
0.390
Why?
Curriculum
1
2019
996
0.380
Why?
Meningitis, Bacterial
1
2012
47
0.380
Why?
Gram-Positive Bacterial Infections
1
2012
70
0.370
Why?
Delivery of Health Care, Integrated
1
2014
262
0.360
Why?
Health Knowledge, Attitudes, Practice
1
2018
1330
0.320
Why?
Anti-Infective Agents
1
2012
256
0.320
Why?
Zidovudine
1
2009
78
0.320
Why?
Homosexuality, Male
2
2022
184
0.300
Why?
Internship and Residency
1
2019
1151
0.300
Why?
Infant, Newborn, Diseases
1
2009
113
0.290
Why?
Infectious Disease Transmission, Vertical
1
2009
184
0.280
Why?
Hematopoietic Stem Cell Transplantation
1
2012
622
0.260
Why?
Colchicine
1
2024
24
0.230
Why?
Pericarditis
1
2024
10
0.230
Why?
Chest Pain
1
2024
91
0.210
Why?
Salmonella Infections
1
2024
57
0.210
Why?
Myocarditis
1
2024
100
0.200
Why?
Antitubercular Agents
2
2014
206
0.200
Why?
Philadelphia
2
2018
49
0.180
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2024
351
0.180
Why?
HIV Seronegativity
1
2018
28
0.150
Why?
Medication Adherence
1
2022
467
0.140
Why?
Health Surveys
1
2018
514
0.130
Why?
Predictive Value of Tests
2
2019
2041
0.130
Why?
Humans
10
2024
137782
0.110
Why?
Africa South of the Sahara
1
2014
48
0.110
Why?
Self Report
1
2019
829
0.110
Why?
Medicaid
1
2018
435
0.110
Why?
Anti-Bacterial Agents
1
2024
1809
0.110
Why?
Continuity of Patient Care
1
2016
284
0.100
Why?
Female
6
2022
73465
0.100
Why?
Male
6
2024
67906
0.100
Why?
Linezolid
1
2012
23
0.100
Why?
Adult
4
2019
38023
0.100
Why?
Middle Aged
4
2019
33554
0.090
Why?
Patient Acceptance of Health Care
1
2018
807
0.090
Why?
Transplantation, Autologous
1
2012
241
0.090
Why?
Immunocompromised Host
1
2012
204
0.090
Why?
Age Factors
1
2018
3305
0.090
Why?
Adolescent
2
2022
21574
0.090
Why?
Retrospective Studies
3
2022
15682
0.090
Why?
Practice Patterns, Physicians'
1
2018
1313
0.080
Why?
Drug Administration Schedule
1
2009
786
0.070
Why?
Cross-Sectional Studies
1
2018
5478
0.070
Why?
Health Services Accessibility
1
2014
991
0.070
Why?
Prospective Studies
1
2019
7623
0.060
Why?
Pregnancy Complications, Infectious
1
2009
394
0.060
Why?
Young Adult
1
2018
13240
0.050
Why?
Electrocardiography
1
2024
629
0.040
Why?
United States
1
2018
14870
0.040
Why?
Diagnosis, Differential
1
2024
1483
0.040
Why?
Infant, Newborn
1
2009
6084
0.040
Why?
Treatment Outcome
1
2012
10837
0.040
Why?
Pregnancy
1
2009
6771
0.030
Why?
Drug Prescriptions
1
2016
245
0.030
Why?
Frasca's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)